Novoprotein(SH:688137) Zheng Quan Zhi Xing·2025-07-28 16:39Summary of Key Points Core Viewpoint - The company, Suzhou Nearshore Protein Technology Co., Ltd., has announced a share repurchase plan aimed at utilizing excess funds from its initial public offering for employee stock ownership plans or equity incentives, with a total expected repurchase amount between 10 million to 20 million RMB [1][2]. Group 1: Repurchase Plan Details - The repurchase plan was first disclosed on July 30, 2024, and is set to be implemented from July 27, 2024, to July 26, 2025 [1]. - The maximum repurchase price is set at 47.00 RMB per share [1]. - The actual number of shares repurchased is 404,337, which accounts for 0.5762% of the total share capital [1][2]. Group 2: Financial Aspects of the Repurchase - The total amount spent on the repurchase is 11.956 million RMB, with the repurchase price ranging from 28.75 RMB to 35.51 RMB per share [2][3]. - The funds used for the repurchase come from excess funds raised during the company's initial public offering, ensuring no significant impact on the company's operational activities or financial status [3]. Group 3: Share Distribution Changes - Before the repurchase, the company had 70,175,439 shares in total, which remains unchanged post-repurchase [4]. - The repurchased shares will be used for employee stock ownership plans or equity incentives, and if not transferred within three years, the company will follow legal procedures to reduce its registered capital [4][5]. Group 4: Compliance and Governance - The company has confirmed that the execution of the repurchase plan aligns with the board's approved proposal, and there are no discrepancies [3]. - During the repurchase period, there were no stock trading activities by the company's directors, supervisors, senior management, or major shareholders [3].